PTGDR and neoplasm: Compared with that in the shRNA-PRR34-AS1 group, the tumor volume was significantly reduced in the sh-PRR34-AS1+miR-498 antagomir and sh-PRR34-AS1+ov-MIEF2 groups (P<0.01;Figure 7A,B).